← All tickers

Is OGN Worth Buying in 2026?

Organon & Co.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether Organon & Co. (OGN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.34% over 10 days); strong 1-year return of +46.1%. Concerns: RSI 85 — overbought, elevated pullback risk. Currently 0.0% off its 52-week high. Score: +4/7.

Ready to act on this? 📈 Trade on Webull

OGN is in a confirmed uptrend, trading above both its 50-day ($13.51) and 200-day ($9.78) moving averages. With an RSI of 84.6, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +46.1% compares to +20.4% for SPY (beat the market by 25.7%).

$10,000 invested 1 year ago → $14,611 today
vs. S&P 500 (SPY) — same period beat market by 25.7%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($9.78)
✓Above 50-day MA ($13.51)
!RSI(14) neutral zone (30–70) — currently 84.6
✓Positive return (+46.1%)
✓Within 10% of period high (−0.0%)
Period Range $13.72
$5.69 $13.72
RSI (14) 84.6
0 · OversoldOverbought · 100

Key Metrics

Price$13.72
Period Return+46.1%
Period High$13.72
Period Low$5.69
Drawdown−0.0%
MA-50$13.51
MA-200$9.78
RSI (14)84.6
Avg Volume (30d)2.6M
vs. SPYbeat by 25.7%
Return Rank#327 of 1252

Trade OGN

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers